March 5, 2020 / 2:28 PM / in a month

BRIEF-Innovation Pharmaceuticals Plans For Mid-Stage Trial Of New Treatment For Ulcerative Colitis

March 5 (Reuters) - Innovation Pharmaceuticals Inc :

* INNOVATION PHARMACEUTICALS PLANS FOR PHASE 2 TRIAL OF NEW TREATMENT FOR ULCERATIVE COLITIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below